Fundamental of Nursing Final Exam |
Newest Exam 2026-2027 |
Leininger's Theory -ANSWER culturally specific nursing care
Watson's Theory -ANSWER transpersonal, promotes WHOLENESS = WATSON
Swanson's Theory -ANSWER caring processes, strategy
incubation period -ANSWER no signs or symptoms, DOESNT KNOW THEY ARE SICK
prodromal period -ANSWER vague, general symptoms, FEELING LIKE POOP, JUST
PRODDING AROUND FEELING BAD
illness period -ANSWER most severe signs and symptoms, VERY SPECIFIC
SYMPTOMS
convalescence -ANSWER gradual recovery after an illness, COMING AROUND AFTER
ILLNESS
direct contact -ANSWER contact between source and susceptible host, ONE LIVING
THING (SOURCE) AND THE HOST
indirect contact -ANSWER contact between host and contaminated INANIMATE
OBJECT,
Droplet contact -ANSWER coughs or sneezes
private room, mask
INFLUENZA
RUBELLA
DIPTHERIA
MUMPS
STREPTOCOCCUS
PERTUSSISS
RHINOVIRUS
"my rhino had the flu, rubella dipped in mumps, and strep that persisted'
Airborne contact -ANSWER smaller droplets or droplet residue
private room, negative pressure, N95 mask
MEASLES
CHICKENPOX (VARICELLA)
HERPES ZOSTER
, TUBERCULOSIS
"my chicken had measles, herpes, and TB"
contact precuations -ANSWER private room, gloves, gowns
MRSA
CLOSTRIDIUM DIFFICILE
SHIGELLA
HERPES SIMPLEX
SCABIES
DISSEMINATED VARICELLA ZOSTER
"have mercy CD! I have shigella, herpes, and scabies!"
Protective environment -ANSWER stem cell transplants
positive air flow, mask gloves and gowns
"this is to protect the patient, not the nurse"
Impaired verbal communication -ANSWER can be related to culture or physical hearing
impairment, can still communicate other ways
PICOT question -ANSWER P- patient population of interest
I- intervention of interest
C- comparison of interest
O- outcome
T- time
Levels of Evidence -ANSWER 1-7 (greatest to least)
preclinical and animal studies -ANSWER basic science research
Phase 1 clinical trials -ANSWER safety in small group of human subjects
Phase 2 and 3 clinical trials -ANSWER safety in larger group of human subjects
Phase 4 clinical trials -ANSWER Testing that continues after drug has already been
approved and gone to market (being sold) to test long term safety
phase 5 population level outcomes and research -ANSWER community
PDSA -ANSWER Plan, Do, Study, Act
performance improvement model
vital sign ranges -ANSWER temp - 96.8-100.4 F
pulse - 60-100 bpm
SpO2 - 95% and up
respirations - 12-20 breathes per minute
blood pressure - 120/80
Newest Exam 2026-2027 |
Leininger's Theory -ANSWER culturally specific nursing care
Watson's Theory -ANSWER transpersonal, promotes WHOLENESS = WATSON
Swanson's Theory -ANSWER caring processes, strategy
incubation period -ANSWER no signs or symptoms, DOESNT KNOW THEY ARE SICK
prodromal period -ANSWER vague, general symptoms, FEELING LIKE POOP, JUST
PRODDING AROUND FEELING BAD
illness period -ANSWER most severe signs and symptoms, VERY SPECIFIC
SYMPTOMS
convalescence -ANSWER gradual recovery after an illness, COMING AROUND AFTER
ILLNESS
direct contact -ANSWER contact between source and susceptible host, ONE LIVING
THING (SOURCE) AND THE HOST
indirect contact -ANSWER contact between host and contaminated INANIMATE
OBJECT,
Droplet contact -ANSWER coughs or sneezes
private room, mask
INFLUENZA
RUBELLA
DIPTHERIA
MUMPS
STREPTOCOCCUS
PERTUSSISS
RHINOVIRUS
"my rhino had the flu, rubella dipped in mumps, and strep that persisted'
Airborne contact -ANSWER smaller droplets or droplet residue
private room, negative pressure, N95 mask
MEASLES
CHICKENPOX (VARICELLA)
HERPES ZOSTER
, TUBERCULOSIS
"my chicken had measles, herpes, and TB"
contact precuations -ANSWER private room, gloves, gowns
MRSA
CLOSTRIDIUM DIFFICILE
SHIGELLA
HERPES SIMPLEX
SCABIES
DISSEMINATED VARICELLA ZOSTER
"have mercy CD! I have shigella, herpes, and scabies!"
Protective environment -ANSWER stem cell transplants
positive air flow, mask gloves and gowns
"this is to protect the patient, not the nurse"
Impaired verbal communication -ANSWER can be related to culture or physical hearing
impairment, can still communicate other ways
PICOT question -ANSWER P- patient population of interest
I- intervention of interest
C- comparison of interest
O- outcome
T- time
Levels of Evidence -ANSWER 1-7 (greatest to least)
preclinical and animal studies -ANSWER basic science research
Phase 1 clinical trials -ANSWER safety in small group of human subjects
Phase 2 and 3 clinical trials -ANSWER safety in larger group of human subjects
Phase 4 clinical trials -ANSWER Testing that continues after drug has already been
approved and gone to market (being sold) to test long term safety
phase 5 population level outcomes and research -ANSWER community
PDSA -ANSWER Plan, Do, Study, Act
performance improvement model
vital sign ranges -ANSWER temp - 96.8-100.4 F
pulse - 60-100 bpm
SpO2 - 95% and up
respirations - 12-20 breathes per minute
blood pressure - 120/80
